Skip to main content
. Author manuscript; available in PMC: 2022 Jul 21.
Published in final edited form as: J Commer Biotechnol. 2022 Jul 17;27(2):5–13. doi: 10.5912/jcb1020

Figure 3:

Figure 3:

Funding distribution for early-stage life science companies with or without collaboration and the collaboration effect on their “Successful Outcome”. (A) NIH funding distribution between companies with “Successful Outcome” and “Unsuccessful Outcomes”. (B) NIH funding distribution for companies with “Successful Outcomes” and “Unsuccessful Outcomes” with or without collaborations mediated by NCI TTC.